Physician profile
Paula L Denevan
NPI 1750488227
$1,039.89
in general payments reported to CMS, 2019-2025
25 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $29.36 · 2021: $19.16 · 2023: $313 · 2024: $85.01 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $202.78 | 2019-2025 | Phasix Mesh, Surgiphor |
| Conmed Corporation | $144.55 | 2023-2025 | Airseal |
| Intuitive Surgical, INC. | $87.61 | 2020-2023 | |
| Csl Behring | $69.49 | 2019-2024 | Kcentra |
| Covidien LP | $59.72 | 2019 | |
| Integra Lifesciences Corporation | $46.51 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $40.63 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $37.34 | 2025 | Journavx |
| Teleflex LLC | $32.27 | 2024-2025 | Titan Sgs, Quikclot |
| Acell, INC. | $32.00 | 2019 | |
| Kci USA, INC. | $28.64 | 2019-2023 | 3m Avagard, Prevena, V.A.C. Dermatac |
| Hologic Sales and Service, LLC | $26.66 | 2025 | Coolseal Generator |
| Portola Pharmaceuticals, LLC | $23.52 | 2019 | |
| Octapharma USA, INC. | $23.15 | 2025 | Fibryga |
| C. R. Bard, INC. & Subsidiaries | $22.00 | 2025 | Bard Urinary Drainage Bag |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.81 | 2019 | |
| Organogenesis INC. | $19.41 | 2025 | Puraply Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $19.16 | 2021 | |
| Mallinckrodt Enterprises LLC | $18.80 | 2019 | |
| Novo Nordisk INC | $18.14 | 2025 | Wegovy |
| Mallinckrodt Hospital Products INC. | $16.41 | 2020 | |
| Innovation Technologies INC | $14.68 | 2023 | Irrisept |
| Kerecis Limited | $14.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $12.00 | 2019 | |
| Kls-Martin L.P. | $9.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Denevan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.